Oral submucous fibrosis: pathogenesis and therapeutic approaches
Abstract Oral submucous fibrosis (OSF), characterized by excessive deposition of extracellular matrix (ECM) that causes oral mucosal tissue sclerosis, and even cancer transformation, is a chronic, progressive fibrosis disease. However, despite some advancements in recent years, no targeted antifibro...
Saved in:
Main Authors: | Jianfei Tang, Junjie Liu, Zekun Zhou, Xinyan Cui, Hua Tu, Jia Jia, Baike Chen, Xiaohan Dai, Ousheng Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2025-02-01
|
Series: | International Journal of Oral Science |
Online Access: | https://doi.org/10.1038/s41368-024-00344-6 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of Platelet Parameters in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma in a Background of Oral Submucous Fibrosis
by: Packiaraj Selvajothi Ranjitham, et al.
Published: (2023-10-01) -
Comment on “Facial Atrophy in Oral Submucous Fibrosis: An Association or a Coincidence”
by: Sonal Grover, et al.
Published: (2016-01-01) -
Novel transcripts of EMT driving the malignant transformation of oral submucous fibrosis
by: Smitha Sammith Shetty, et al.
Published: (2025-01-01) -
Epigallocatechin-3-gallate inhibits the collagen accumulation of oral submucous fibrosis induced by arecoline
by: Ge Gao, et al.
Published: (2025-01-01) -
Maintenance of Increased Mouth Opening in Oral Submucous Fibrosis Patient Treated with Nasolabial Flap Technique
by: Milind Naphade, et al.
Published: (2014-01-01)